218 related articles for article (PubMed ID: 18473966)
1. Towards a gene therapy clinical trial for epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy approaches for epidermolysis bullosa.
Ferrari S; Pellegrini G; Mavilio F; De Luca M
Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
[TBL] [Abstract][Full Text] [Related]
4. Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa.
Dellambra E; Pellegrini G; Guerra L; Ferrari G; Zambruno G; Mavilio F; De Luca M
Hum Gene Ther; 2000 Nov; 11(16):2283-7. PubMed ID: 11084687
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy for Epidermolysis Bullosa.
Marinkovich MP; Tang JY
J Invest Dermatol; 2019 Jun; 139(6):1221-1226. PubMed ID: 31068252
[TBL] [Abstract][Full Text] [Related]
6. Advances in Gene/Cell Therapy in Epidermolysis Bullosa.
Murauer EM; Koller U; Pellegrini G; De Luca M; Bauer JW
Keio J Med; 2015; 64(2):21-5. PubMed ID: 26050701
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
Hsu CK; Wang SP; Lee JY; McGrath JA
Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy of skin adhesion disorders (mini review).
Cavazza A; Mavilio F
Curr Pharm Biotechnol; 2012 Aug; 13(10):1868-76. PubMed ID: 22250710
[TBL] [Abstract][Full Text] [Related]
9. Sustained phenotypic reversion of junctional epidermolysis bullosa dog keratinocytes: Establishment of an immunocompetent animal model for cutaneous gene therapy.
Spirito F; Capt A; Del Rio M; Larcher F; Guaguere E; Danos O; Meneguzzi G
Biochem Biophys Res Commun; 2006 Jan; 339(3):769-78. PubMed ID: 16316622
[TBL] [Abstract][Full Text] [Related]
10. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa.
De Rosa L; Secone Seconetti A; De Santis G; Pellacani G; Hirsch T; Rothoeft T; Teig N; Pellegrini G; Bauer JW; De Luca M
Cell Rep; 2019 May; 27(7):2036-2049.e6. PubMed ID: 31091444
[TBL] [Abstract][Full Text] [Related]
11. Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.
Cavazza A; Cocchiarella F; Bartholomae C; Schmidt M; Pincelli C; Larcher F; Mavilio F
Gene Ther; 2013 Sep; 20(9):949-57. PubMed ID: 23615186
[TBL] [Abstract][Full Text] [Related]
12. Corrective transduction of human epidermal stem cells in laminin-5-dependent junctional epidermolysis bullosa.
Dellambra E; Vailly J; Pellegrini G; Bondanza S; Golisano O; Macchia C; Zambruno G; Meneguzzi G; De Luca M
Hum Gene Ther; 1998 Jun; 9(9):1359-70. PubMed ID: 9650620
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of inherited skin adhesion disorders: a critical overview.
De Luca M; Pellegrini G; Mavilio F
Br J Dermatol; 2009 Jul; 161(1):19-24. PubMed ID: 19466960
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural findings in epidermolysis bullosa.
Smith LT
Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
[TBL] [Abstract][Full Text] [Related]
15. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa.
Umegaki-Arao N; Pasmooij AM; Itoh M; Cerise JE; Guo Z; Levy B; Gostyński A; Rothman LR; Jonkman MF; Christiano AM
Sci Transl Med; 2014 Nov; 6(264):264ra164. PubMed ID: 25429057
[TBL] [Abstract][Full Text] [Related]
17. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.
Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA
J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041
[TBL] [Abstract][Full Text] [Related]
18. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes.
Kueckelhaus M; Rothoeft T; De Rosa L; Yeni B; Ohmann T; Maier C; Eitner L; Metze D; Losi L; Secone Seconetti A; De Luca M; Hirsch T
N Engl J Med; 2021 Dec; 385(24):2264-2270. PubMed ID: 34881838
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo gene therapy cures a blistering skin disease.
Featherstone C; Uitto J
Trends Mol Med; 2007 Jun; 13(6):219-22. PubMed ID: 17416553
[TBL] [Abstract][Full Text] [Related]
20. BP180 gene delivery in junctional epidermolysis bullosa.
Seitz CS; Giudice GJ; Balding SD; Marinkovich MP; Khavari PA
Gene Ther; 1999 Jan; 6(1):42-7. PubMed ID: 10341874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
